Taking a step back to 2017, a five-year time, Australian project to create just-in-time implants, helped to transform tumor surgeries and involved 3D printing and advanced manufacturing, which contributed to the development of the fast and efficient method of their production and implementation. With the collaboration of RMIT University, The University of Sydney, The University of Technology Sydney (UTS), University of Melbourne and St Vincent’s Hospital, as well as the funding from the Stryker company specializing in medical devices, the production and delivery of such implants to the patients is much more efficient in time. Both domestically and internationally.
As the research and clinical trials are now worth around $12,2 million, there is undoubtedly a big advantage in implementing the following approach. Combining additive manufacturing with robotic surgeries, the implant produced this way can be fitted perfectly with the low probability of an error and if there is any, having the whole 3D printing process just around the corner. In general, this helps to save a lot of precious time.
What is the crucial aim of the just-in-time implants project?
“Our aim is to bring the technology to the theatre.” says the leader and researcher of the project, Professor Milan Brandt. As the technology is constantly evolving and enabling to combine multiple methods and approaches, just-in-time implants can turn out to be one of the most effective ways to design, print out, and use them out in the patient precisely in order to treat the bone cancer better. This is actually helping to prevent tumor development, worsening the patient state while weeks needed to provide a custom-made implant by the traditional method, and minimize the time of recovery and hospital care.
Also, the project guarantees to develop a competitive advantage both internationally and domestically. While the cooperation is very important here, the local market, as well as job opportunities in engineering, medical and technological industries, may experience rapid growth. However, it’s not about taking into consideration only an Australian one. With the instant expansion of the just-in-time solution, we’re speaking about others, international markets as well.
What are the main advantages that the “just-in-time implants” solution would bring?
Definitely, one of the main benefits of developing just-in-time implants is boosting the collaboration between Australian and other markets around the world. Because Austalia can provide them an advanced implants manufacturing report based on years of research investments, there is a high potential to enhance global cooperation. As Stryker’s South Pacific Director of Research and Development Rob Wood states “Australia is leading the way globally in developing and implementing new manufacturing models and technology in the medical space – combining robotic surgery and additive manufacturing,”. This statement can only confirm the point of investment in such innovative and advance solutions, which just-in-time implants are.
What do you think about such printing implants at the hospital? Let us know in the comment below!